USD/BTC = $77,594
Block 934,613
Here are the stocks I plan on buying this week:Here are the stocks I plan on buying this week:
🐂 = Bull Case
🐻 = Bear Case
| Company | Ticker | Price | Sat Price | 🐂 🐻 | BTC/Share | More Info |
| Cathedra | CBTTF | $0.53 | 683 | See week #1 | 6 | Investor Relations Page |
| Fold | FLD | $1.94 | 2,462 | See week #1 | 3,281 | Investor Relations Page |
| LQWD Technologies | LQWD | $0.81 | 1,044 | See week #2 | 864 | Investor Relations Page |
| Kindly MD | NAKA | $0.35 | 451 | See week #3 | 1,227 | Investor Relations Page |
| Strive | ASST | $0.80 | 1,031 | See week #4 | 1,033 | Investor Relations Page |
| BTC Development Corp. | BDCI | $10.10 | 13,034 | See week #9 | 0 | SPAC company no page yet |
| Twenty-One | XXI | $7.55 | 9,743 | See week #15 | 12,559 | Investor Relations Page |
| Fractyl Health | GUTS | $0.50 | 645 | See week #18 | 0 | Investor Relations Page |
| Bitcoin Depot | BTM | $1.03 | 1,333 | Blok’s daily stock! | 330 | Investor Relations Page |
| BitGo | BTGO | $13.33 | 17,262 | See below | 2,018 | IPO Prospectus Report |
Latest Updates:Latest Updates:
BitGo insider dumps shares:BitGo insider dumps shares:
Fold CEO Writes a letter about the future of foldFold CEO Writes a letter about the future of fold
Highlights include
- Fold will be free (no more Fold + ($9.99 a month sub)
- Zero fee spreads for Recurring boys and direct deposits
- Upgraded app experience
- Credit card launch 1.5% BTC back on all purchases up to 4%
- Better banking rails (much needed!)
- Increased Partnerships (like steak-n-shake)
GUTS gets gutted:GUTS gets gutted:
Stocked TANKED due to their trial failing to deliver results on weight loss.
Weight maintenance benefit Across the prespecified efficacy population, Revita-treated patients experienced a 4.5% weight regain vs 7.5% in the sham arm at 6 months (p=0.07, one-sided), consistent with meaningful and sustained attenuation of the expected post-GLP-1 rebound trajectory.An exploratory analysis of patients who achieved above median weight loss during GLP-1 run-in (n=20) showed that Revita-treated participants experienced 4.2% weight regain versus 13.3% with sham at 6 months, corresponding to an approximately 70% relative reduction in post-GLP-1 weight regain.
Source
But all is not lost!
A bullish Stocktwits user said the product that reduces sweet cravings could be extremely profitable, highlighting huge market potential.Another user said they trusted the management and would hold the stock.
Revita, the main product from Fractyl Health, is meant to reshape the lining of the small intestine through a single, minimally invasive procedure. The FDA has granted Revita Breakthrough Device designation to help people maintain weight after stopping GLP-1 treatments.
Source
Commentary:Commentary:
Limit orders are in place! I am excited for Fold and what they can do in 2026. Still waiting for XXI to give us some insight in to what they are doing. GUTS was tough to stomach but that how it goes with investing. I am still buying until they go bankrupt or I do! Far as BitGO dumping shares it is expected. Insiders must of been holding for years before they can finally realize the gain by going public. Besides I will gladly take the shares. I think BitGO has nice opportunity to be the bank of the future. If not bank then the most trusted custody provider for other companies and family offices.
Until next week!